^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    conatumumab (AMG 655)

    i
    Company:
    Amgen
    Drug class:
    TRAIL R2 agonist
    Related drugs:
    Apply
    QUILT-2.018: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal Carcinoma (NCT00813605)
    Phase 2
    NantCell, Inc.
    Completed
    Last update posted :
    10/27/2016
    Initiation :
    03/01/2009
    Primary completion :
    01/01/2011
    Completion :
    06/01/2012
    KRAS
    |
    KRAS mutation
    |
    5-fluorouracil • irinotecan • leucovorin calcium • ganitumab (AMG 479) • conatumumab (AMG 655)
    Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer (NCT01940172)
    Phase 1b
    TetraLogic Pharmaceuticals
    Completed
    Last update posted :
    01/14/2016
    Initiation :
    11/01/2013
    Primary completion :
    09/01/2015
    Completion :
    12/01/2015
    MUC16
    |
    birinapant (IGM-9427) • conatumumab (AMG 655)